LFST
LifeStance Health Group, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
LifeStance Health Group, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report3 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
No other changes.
No other changes.
No thesis.
Annual filing, covered
10-K parsed · Feb 25 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Feb 25 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
+2.80%
vs ±10.0% implied · ×0.28
shaded = implied · ▲▼ = realized
LifeStance Health Group, Inc.
13.39
pre 13.45 +1.43%
| Manager | Value | % base | |
|---|---|---|---|
| TPG GP A | $1.2B | 29.69% | −20.20% |
| FMR | $623.9M | 15.47% | −0.74% |
| BlackRockindex-like | $389.3M | 9.66% | +100.43% |
| Summit Partners L P | $249.7M | 6.19% | −20.20% |
| Vanguard Portfolioindex-like | $149.5M | 3.71% | +44.19% |
| Manager | Value | % base | |
|---|---|---|---|
| TPG GP A | $1.2B | 29.69% | −20.20% |
| FMR | $623.9M | 15.47% | −0.74% |
| BlackRockindex-like | $389.3M | 9.66% | +100.43% |
| Summit Partners L P | $249.7M | 6.19% | −20.20% |
| Vanguard Portfolioindex-like | $149.5M | 3.71% | +44.19% |
Same SIC code · 6
Same SEC industry code: Privia Health Group, Inc., GeneDx Holdings Corp., Pennant Group, Inc. and 3 more; of LifeStance Health Group, Inc.'s 6 closest co-movers, none share that code.
Same SIC code · 6
Same SEC industry code: Privia Health Group, Inc., GeneDx Holdings Corp., Pennant Group, Inc. and 3 more; of LifeStance Health Group, Inc.'s 6 closest co-movers, none share that code.
Bull1
Bear2
Largest filed tie
15.00%
of LFST revenue · Elevance Health
Tall tick = annual report · Source: EDGAR
—
Expected move
Inputs8Q avg ±10.6%·×1.08·fair
straddle ±11.4%
spot 13.37exp Nov 20ATM strike 13ATM straddle 1.80IV 77%